GLP-1 Drugs Linked to 17% Drop in Worker Sick Leave, Study Finds

Source: Google News - HealthGLP-1 drugs could lead to cost savings for workers and their employers by reducing employee sick leave, a U.S. government study finds. Researchers found that patients who used the drugs, sold under brand names such as Ozempic and Wegovy, took 17% less long-term sick leave than people who didn't. The study, published this month by the National Bureau of Economic Research, defines long-term sick leave as illness-related absences lasting more than...